Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
aXichem ABOSTO:AXIC A -7.91%65 Days Inventory is 1,925.92 as of Mar. 2026, which is 260% above its 10-year median of 535.72. GuruFocus rates OSTO:AXIC A with a GF Score™ of 65/100 and a GF Value™ of kr3.59 (Modestly Undervalued). Among 1,542 Chemicals companies, aXichem AB ranks worse than 96.82% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). aXichem AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr7.77 Mil. aXichem AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr0.37 Mil.
Hence, aXichem AB's Days Inventory for the
three
months ended in Mar. 2026 was 1,925.92.
The historical rank and industry rank for aXichem AB's Days Inventory or its related term are showing as below:
OSTO:AXIC A'
s Days Inventory Range Over the Past 10 Years
Min: 134.74 Med: 535.72 Max: 6303.55
Current: 345.5
During the past 13 years, aXichem AB's highest Days Inventory was 6303.55. The lowest was 134.74. And the median was 535.72.
OSTO:AXIC A's Days Inventory is ranked worse than 96.82% of 1542
companies
in the Chemicals industry
Industry Median: 80.37
vs OSTO:AXIC A: 345.50
aXichem AB's Days Inventory
declined
from Mar. 2025 (3,340.24) to Mar. 2026 (1,925.92).
Inventory Turnover measures how fast the company turns over its inventory within a year.
aXichem AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.05.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
aXichem AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.03.
aXichem AB (OSTO:AXIC A) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
aXichem AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
aXichem AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
aXichem AB Days Inventory Related Terms
aXichem AB Days Inventory Historical Data
* Premium members only.
The historical data trend for aXichem AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:AXIC A vs LIN, SHW, ECL: Days Inventory Comparison
For the Specialty Chemicals subindustry, aXichem AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Days Inventory vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where aXichem AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (OSTO:AXIC A) has a Days Inventory of 1,925.92 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on aXichem AB and its competitors. This is 260% above median its historical median of 535.72. Over the past decade, aXichem AB's Days Inventory has ranged from 134.74 to 6,303.55. According to the industry distribution chart, aXichem AB ranks #1493 out of 1542 companies in the Chemicals industry, placing it in the top 96.8%.
Is aXichem AB's Days Inventory too high?
aXichem AB's current Days Inventory of 1,925.92 is 260% above median its 10-year median of 535.72. Over the past 10 years, this metric has ranged from a low of 134.74 to a high of 6,303.55. The Chemicals industry median Days Inventory is 80.37. aXichem AB's value of 1,925.92 is 2296.3% above this industry median. Based on the distribution chart, aXichem AB ranks #1493 out of 1542 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Days Inventory compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #1493 out of 1542 companies for Days Inventory. This places aXichem AB in the lower half of its industry. The industry median Days Inventory is 80.37. aXichem AB's value of 1,925.92 is 2296.3% above this benchmark. Historically, aXichem AB's own Days Inventory has ranged from 134.74 to 6,303.55 over the past decade. While the company's 10-year median is 535.72 vs. the industry median of 80.37, aXichem AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Chemicals company?
The median Days Inventory among Chemicals companies is 80.37, based on 1,542 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aXichem AB's current Days Inventory of 1,925.92 is 2296.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median Days Inventory is 80.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Days Inventory is 1,925.92, which is 260% above median its own 10-year median of 535.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Modestly Undervalued. The stock's GF Value™ is kr3.59, compared to a current price of kr2.56 — trading 28.7% below its estimated fair value. The current Days Inventory is 1,925.92, which is 260% above median its 10-year median of 535.72 and 2296.3% above the Chemicals industry median of 80.37. aXichem AB's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current Days Inventory is 1,925.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of kr2.56 is trading 28.7% below its estimated GF Value™ of kr3.59.
GuruFocus considers aXichem AB to be Modestly Undervalued.
Key valuation signals for OSTO:AXIC A:
Days Inventory: 1,925.92 (260% above median its 10-year median of 535.72)
GF Value™: kr3.59 vs. price of kr2.56 (28.7% below fair value)
Industry Position: 2296.3% above the Chemicals median (#1493 of 1542)
No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score
Get the complete analysis for OSTO:AXIC A
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:AXIC A has been successfully added to your 
